Work

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

Year: 2010

Type: article

Study design: Study Protocol

Source: American Heart Journal

DOI: 10.1016/j.ahj.2010.07.006

Authors: Harvey White, Claes Held, Ralph Stewart, David Watson, Robert Harrington, Andrzej Budaj, Ph. Gabriel Steg, Christopher P. Cannon, Susan Krug-Gourley, Janet Wittes, Trupti Trivedi, Elizabeth Tarka, Lars Wallentin

Institutions: Auckland City Hospital, Uppsala University, Uppsala University Hospital, GlaxoSmithKline (United States), Duke Clinical Research Institute, Grochowski Hospital, Inserm, Hôpital Bichat-Claude-Bernard, Université Paris Diderot, Brigham and Women's Hospital, Thrombolysis in Myocardial Infarction Study Group, Statistics Collaborative

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, GlaxoSmithKline

OpenAlex ID: W2167630046

FWCI: 17.29

Cites: 24

Cited by: 126

Related to: 10